Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients

Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients

Background: The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in kidney transplant (KT) recipients. Here, we provide a thorough assessment of the immunogenicity of a three-dose COVID-19 vaccine regimen in this population. Methods: We performed a prospective longitudinal study in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Filippo Massa, PhD, Marion Cremoni, MD, Alexandre Gérard, MD, Hanen Grabsi, Lory Rogier, Mathilde Blois, MD, Chloé Couzin, MD, Nadia Ben Hassen, Matthieu Rouleau, PhD, Susana Barbosa, PhD, Emanuela Martinuzzi, PhD, Julien Fayada, Ghislaine Bernard, MD-PhD, Guillaume Favre, MD-PhD, Paul Hofman, MD-PhD, Vincent L.M. Esnault, MD-PhD, Cecil Czerkinsky, MD-PhD, Barbara Seitz-Polski, MD-PhD, Nicolas Glaichenhaus, PhD, Antoine Sicard, MD-PhD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
COVID-19
mRNA vaccine
variants of concern, kidney transplantation
Immunogenicity
Medicine
R
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/6aec33f0dd6e4ddba8069d07e0e047f1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares